But exercise alone is not enough to lose weight, says Professor Johannes Wechsler, a doctor and nutrition specialist based in Germany.In an interview with dpa, he explains why your diet matters when ...

Debbie Ramos tracked her physical activity with Fitbit and used the Headspace app to mediate when stress caused comfort food cravings.

The Alliance for Pharmacy Compounding told the FDA last week that Novo Nordisk's weight loss medicine semaglutide is not too ...

Chronic inflammation is increasingly recognized as a central factor in various health issues, from obesity and diabetes to ...

More than half of Americans qualify for GLP-1 receptor agonist drugs, but many can't afford them. Experts share cheaper ...

The randomized clinical trial showed that Zepbound patients achieved 47% more relative weight loss than Wegovy patients.

Zepbound, the new GLP-1 weight-loss drug from Eli Lilly & Co., has outperformed its main competitor, Wegovy, in a clinical ...

After struggling with weight gain for three years, Sarah Bisacca was diagnosed with insulin resistance. Here's how she was learned to manage it.

Participants in Wegovy clinical trials were more likely to report “severe gastrointestinal adverse reactions,” the FDA's ...

Adults who take Zepbound lose more weight than those who take competitor weight loss drug Wegovy, according to new clinical ...

Ozempic promotes weight loss by mimicking the GLP-1 hormone the body naturally produces after eating, so users feel fuller ...

Lilly's Zepbound outperforms Novo Nordisk's Wegovy in weight loss study, boosting market-share gains and stock prices.